Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

7.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.2K
Structure and Function of Platelets01:18

Structure and Function of Platelets

1.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.6K
Inflammation01:38

Inflammation

55.6K
Overview
55.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

660
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
660
Introduction to Hemostasis01:05

Introduction to Hemostasis

9.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
9.1K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

948
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
948

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid function and outcomes in heart failure with mildly reduced ejection fraction: insights from a large, retrospective registry.

Endocrine·2026
Same author

Cardio-Oncologic Considerations in Heart Failure With Mildly Reduced Ejection Fraction: Prevalence and Prognostic Impact of Malignancies.

Journal of the American Heart Association·2026
Same author

Even mild elevations of C-reactive protein levels predict long-term prognosis in heart failure with mildly reduced ejection fraction.

Clinical research in cardiology : official journal of the German Cardiac Society·2026
Same author

CYP2C19 Polymorphism and Platelet Aggregation-Associated Risks in Atrial Fibrillation Patients Undergoing PCI.

Clinical and translational science·2026
Same author

Dynamic changes in mean corpuscular volume could be integrated into longitudinal prediction frameworks for individualized risk assessment in the ICU setting: A retrospective study.

Science progress·2026
Same author

Editorial: Interplay of immunothrombosis and thromboinflammation in health and disease.

Frontiers in cardiovascular medicine·2026

Related Experiment Video

Updated: Sep 26, 2025

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

457

Platelet Subtypes in Inflammatory Settings.

Muataz Ali Hamad1,2,3, Krystin Krauel1,4, Nancy Schanze1,4

  • 1Department of Cardiology and Angiology I, Heart Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Frontiers in Cardiovascular Medicine
|April 25, 2022
PubMed
Summary

Platelets, crucial for blood clotting, also significantly influence inflammation and immune responses. Understanding diverse platelet subpopulations and their roles in health and disease is vital for advancing medical research.

Keywords:
immunologyinflammationplateletsprocoagulant plateletsreticulated plateletsvascular

More Related Videos

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.9K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.1K

Related Experiment Videos

Last Updated: Sep 26, 2025

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry
08:04

Analyzing Platelet Subpopulations by Multi-color Flow Cytometry

Published on: June 10, 2025

457
Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice
11:18

Real-time Imaging of Heterotypic Platelet-neutrophil Interactions on the Activated Endothelium During Vascular Inflammation and Thrombus Formation in Live Mice

Published on: April 2, 2013

15.9K
Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.1K

Area of Science:

  • Immunology
  • Hematology
  • Cell Biology

Background:

  • Platelets are key regulators of hemostasis and thrombosis.
  • Beyond clotting, platelets actively modulate inflammatory and immune responses via surface receptors and secreted factors.
  • Platelets contribute to leukocyte recruitment in inflamed tissues.

Purpose of the Study:

  • To review the role of distinct platelet subpopulations in inflammation.
  • To highlight the phenotypic variation of platelets based on function and age.
  • To discuss tools for investigating platelet subpopulations in inflammatory contexts.

Main Methods:

  • Review of existing literature on platelet function and subpopulations.
  • Discussion of advancements in proteomics, including mass spectrometry-driven approaches.
  • Exploration of methods for studying platelet phenotypes in physiological and pathological states.

Main Results:

  • Platelets exhibit functional and age-based heterogeneity, leading to distinct subtypes (e.g., procoagulant, immature/reticulated).
  • These variations influence their capacity to modulate inflammatory and immune processes.
  • Proteomics advancements enable deeper investigation into platelet molecular mechanisms.

Conclusions:

  • Recognizing and studying diverse platelet phenotypes is crucial for understanding their significance in health and disease.
  • Further research is needed to fill knowledge gaps regarding platelet subpopulations in various conditions.
  • Investigating platelet subpopulations offers potential for novel therapeutic strategies in inflammatory diseases.